Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: An open-label, prospective trial

Pharmacopsychiatry

Volumn 40, Issue 2, 2007, Pages 68-71

  Calandre, Elena Pita ^a,b   Morillas Arques, P ^a   Rodriguez Lopez, C M ^a   Rico Villademoros, F ^a   Hidalgo, J ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Instituto de Neurociencias   (Spain)

Author keywords

Fibromyalgia; Pain; Pregabalin; Quetiapine

Indexed keywords

PREGABALIN; QUETIAPINE;

ADULT; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COORDINATION DISORDER; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FIBROMYALGIA; HUMAN; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

ADULT; ANALGESICS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FIBROMYALGIA; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 34247857419     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-972572     Document Type: Article

References (19)

1. Aaron LA, Buchwald D: Chronic diffuse muskuloskeletal pain, fibromyalgia and comorbid unexplained medical conditions. Best Pract Res Clin Rheumatol 2003; 17: 563-574
2. Arnold LM: Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res Ther 2006; 8: 212 ; doi:10.1186/ar1971 (Epub ahead of print)
3. Ben Menachem E: Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004; 45: 13-18
4. Bennett RM, Kamin M, Karim R, Rosenthal N: Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia: a double-blind, randomized, placebo-controlled study. Am J Med 2003; 114: 537-545
5. Crofford LJ: Pharmaceutical treatment options for fibromyalgia. Curr Rheumatol Rep 2004; 6: 274-280
6. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE et al: Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52: 1264-1273
7. Feltner DE, Crockatt JC, Dubovsky SJ, Cohn CK, Shrivastava RK, Targum SD et al: A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 2003; 23: 240-249
8. Fishbain DA, Cutler RB, Lewis J, Cole B, Rosomoff RS, Rosomoff HL: Do the second generation "atypical neuroleptics" have analgesic properties? A structured evidence-base review. Pain Med 2005; 5: 359-365
9. Fossaluza V, De Vita S: Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome. Int J Clin Pharm Res 1992; 12: 99-102
10. Golbenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C: A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39: 1852-1859
11. Goldenberg DL, Burckhardt C, Crofford L: Management of fibromyalgia syndrome. JAMA 2004; 292: 2388-2395
12. Hidalgo J, Rico-Villademoros F, Calandre EP: An open-label study of quetiapine in the treatment of fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 71-77
13. Holman AJ, Myers RR: A randomized, double-blind, placebo-controlled trial of pramiprexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 2005; 52: 2495-2505
14. Karow A, Schnedler D, Naber D: What would the patient choose? Subjective comparison of atypical and typical neuroleptics. Pharmacopsychiatry 2006; 39: 47-51
15. Kavoussi R: Pregabalin: from molecule to medicine. Eur Neuropsychopharmacol 2006; 16: 128-133
16. Kazis LE, Anderson JJ, Meenan RF: Effect sizes for interpreting changes in health status. Med Care 1989; 27: 178-189
17. Mease P: Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 2005; 32: 6-21
18. Pande AC, Crockatt JC, Feltner DE, Janney CA, Smith WT, Weisler R et al: Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 2003; 160: 533-540
19. Samborski W, Lezanska-Szpera M, Rybakowsky JK: Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry 2004; 37: 168-170